| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0099 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.073 | 0.2 |